X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (8996) 8996
Publication (565) 565
Book Chapter (152) 152
Dissertation (122) 122
Conference Proceeding (92) 92
Book Review (87) 87
Book / eBook (9) 9
Data Set (5) 5
Web Resource (5) 5
Magazine Article (3) 3
Government Document (2) 2
Paper (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (4451) 4451
drug interactions (3424) 3424
pharmacology & pharmacy (3298) 3298
drug-drug interactions (2886) 2886
index medicus (2792) 2792
animals (2329) 2329
male (2170) 2170
drug-drug interaction (2169) 2169
pharmacokinetics (1541) 1541
female (1448) 1448
adult (973) 973
rats (928) 928
middle aged (859) 859
metabolism (820) 820
in-vitro (710) 710
receptors, drug - drug effects (680) 680
aged (633) 633
drug–drug interaction (581) 581
analysis (565) 565
pharmacology (562) 562
inhibition (540) 540
dose-response relationship, drug (537) 537
drugs (502) 502
drug–drug interactions (491) 491
mice (488) 488
toxicology (486) 486
p-glycoprotein (472) 472
kinetics (431) 431
cytochrome p450 (429) 429
drug interaction (406) 406
cytochrome p-450 enzyme system - metabolism (400) 400
cytochrome p-450 (396) 396
biochemistry & molecular biology (389) 389
young adult (378) 378
area under curve (373) 373
drug therapy, combination (361) 361
in vitro techniques (359) 359
pharmacology/toxicology (339) 339
models, biological (337) 337
research (337) 337
chemistry, multidisciplinary (327) 327
enzymes (318) 318
liver (315) 315
human liver-microsomes (310) 310
drug therapy (304) 304
adolescent (293) 293
prediction (291) 291
administration, oral (275) 275
rats, sprague-dawley (268) 268
pharmacy (264) 264
therapy (263) 263
cytochrome p-450 cyp3a - metabolism (262) 262
metabolites (259) 259
polypharmacy (256) 256
cross-over studies (249) 249
chemistry, medicinal (248) 248
liver - metabolism (248) 248
cancer (246) 246
cyp3a4 (245) 245
time factors (244) 244
pharmaceutical preparations - metabolism (243) 243
complications and side effects (241) 241
microsomes, liver - metabolism (241) 241
physiological aspects (237) 237
cells, cultured (235) 235
pharmacodynamics (233) 233
medicine & public health (228) 228
drug design (225) 225
oncology (223) 223
aged, 80 and over (221) 221
safety (219) 219
biomedicine (216) 216
protein binding (212) 212
article (211) 211
risk factors (211) 211
microsomes, liver - drug effects (210) 210
microsomes, liver - enzymology (209) 209
enzyme inhibitors - pharmacology (207) 207
internal medicine (207) 207
expression (206) 206
drug metabolism (203) 203
induction (199) 199
warfarin (193) 193
drug synergism (187) 187
dosage and administration (186) 186
risk (185) 185
care and treatment (182) 182
healthy-volunteers (177) 177
binding sites (175) 175
absorption (172) 172
hiv (172) 172
health aspects (171) 171
toxicity (171) 171
ketoconazole (170) 170
medicine (170) 170
receptors, drug - metabolism (169) 169
cytochrome p-450 enzyme inhibitors (168) 168
hiv infections - drug therapy (168) 168
liver - drug effects (167) 167
prevalence (167) 167
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5906) 5906
Japanese (1798) 1798
Chinese (1430) 1430
German (63) 63
French (42) 42
Russian (27) 27
Spanish (25) 25
Slovenian (10) 10
Czech (7) 7
Korean (6) 6
Portuguese (6) 6
Polish (5) 5
Hungarian (2) 2
Italian (2) 2
Bulgarian (1) 1
Norwegian (1) 1
Slovak (1) 1
Thai (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Clinical Pharmacokinetics, ISSN 0312-5963, 1/2011, Volume 50, Issue 1, pp. 25 - 39
Etravirine (formerly TMC125) is a non-nucleoside reverse transcriptase inhibitor (NNRTI) with activity against wild-type and NNRTI-resistant strains of HIV-1.... 
Pharmacotherapy | Internal Medicine | Medicine & Public Health | Pharmacology/Toxicology | Drug-interactions | Ribavirin, drug interactions | Antiepileptic-drugs, drug interactions | Simvastatin, drug interactions | Voriconazole, drug interactions | Dexamethasone, drug interactions | Fibric-acid-derivatives, drug interactions | Rifampicin, drug interactions | Opioid-analgesics, drug interactions | Antidepressants, drug interactions | Atorvastatin, drug interactions | Antiretrovirals, drug interactions | Anti-infectives, drug interactions | Histamine-H2-receptor-antagonists, drug interactions | Diazepam, drug interactions | Ketoconazole, drug interactions | Fluconazole, drug interactions | Hypericum, drug interactions | HMG-CoA-reductase-inhibitors, drug interactions | Oral-contraceptives, drug interactions | Sildenafil, drug interactions | Omeprazole, drug interactions | Buprenorphine, drug interactions | Rosuvastatin, drug interactions | Non-nucleoside-reverse-transcriptase-inhibitors, drug interactions | Type-5-cyclic-nucleotide- phosphodiesterase-inhibitors, drug interactions | Corticosteroids, drug interactions | Paroxetine, drug interactions | Fluoxetine, drug interactions | Rifapentine, drug interactions | Ethinylestradiolnorethisterone, drug interactions | Ranitidine, drug interactions | Etravirine, drug interactions | Antifungals, drug interactions | Digoxin, drug interactions | Warfarin, drug interactions | Methadone, drug interactions | Fluvastatin, drug interactions | Rifabutin, drug interactions | Sertraline, drug interactions | Azithromycin, drug interactions | Pharmacokinetics | Calcineurin-inhibitors, drug interactions | Itraconazole, drug interactions | Proton-pump-inhibitors, drug interactions | Clarithromycin, drug interactions | TRANSCRIPTASE INHIBITOR ETRAVIRINE | METABOLISM | EXPERIENCED HIV-1-INFECTED PATIENTS | TMC125 ETRAVIRINE | HIV-NEGATIVE VOLUNTEERS | DOUBLE-BLIND | PHARMACOLOGY & PHARMACY | HUMAN LIVER | PLACEBO-CONTROLLED TRIAL | 2 DIFFERENT FORMULATIONS | CLINICAL PHARMACOKINETICS | Reverse Transcriptase Inhibitors - adverse effects | Reverse Transcriptase Inhibitors - pharmacokinetics | Drug Interactions | Drug-Related Side Effects and Adverse Reactions | Humans | Pyridazines - pharmacokinetics | Drug Therapy, Combination | Pyridazines - adverse effects | Etravirine | Drug interactions | Physiological aspects | Dosage and administration | Research | Properties | Drug therapy | HIV infection
Journal Article
Journal Article
Journal Article
Journal Article
by Qian, S and Liang, SQ and Yu, HY
PLOS COMPUTATIONAL BIOLOGY, ISSN 1553-7358, 05/2019, Volume 15, Issue 5, pp. e1007068 - e1007068
Journal Article